Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil

N. Kwon (Brentford, Middlesex, United Kingdom), E. Pizzichini (N/A, Brazil), A. Bansal (Cambridge, United Kingdom), F. Albers (Research Triangle Park, NC, United States of America), N. Barnes (Brentford, Middlesex, United Kingdom), J. Riley (Stevenage, Hertfordshire, United Kingdom), A. Lima-Matos (Bahia, Brazil), E. Ponte (São Paulo, Brazil), A. Cruz (Bahia, Brazil)

Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session: Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type: Thematic Poster
Number: 1123
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kwon (Brentford, Middlesex, United Kingdom), E. Pizzichini (N/A, Brazil), A. Bansal (Cambridge, United Kingdom), F. Albers (Research Triangle Park, NC, United States of America), N. Barnes (Brentford, Middlesex, United Kingdom), J. Riley (Stevenage, Hertfordshire, United Kingdom), A. Lima-Matos (Bahia, Brazil), E. Ponte (São Paulo, Brazil), A. Cruz (Bahia, Brazil). Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil. 1123

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019



Late Breaking Abstract - Blood eosinophil counts and treatment response in COPD: analyses of IMPACT
Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS
Year: 2018



Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019




Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Late Breaking Abstract - Comparison of the blood transcriptomic profiles of adults and children from the U-BIOPRED asthma study
Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Year: 2017




Late Breaking Abstract - The first direct comparison between BAL-fluid and the PExA methodology in healthy individuals.
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017



Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018



Late Breaking Abstract - Prognostic analysis of secondary pulmonary alveolar proteinosis: Inspection by one of the world’s largest data.
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018




Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time.
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019




Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Late Breaking Abstract - Elevated NETosis and migration but impaired anti-microbial responses by COVID-19 neutrophils
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR)
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017

Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017



Late Breaking Abstract: A methodological study of airway epithelial cells in children
Source: Annual Congress 2010 - Childhood pneumonia: from prevention to complications
Year: 2010

Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Late Breaking Abstract - Long-term variability of blood eosinophils in COPD patients by GOLD 2017 staging, and gender bias
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Late Breaking Abstract - Financial burden of ILD – a claims data based study
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017


Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020